- Home
- PYPD vs MCVT Comparison
PYPD vs MCVT Comparison
Compare PYPD & MCVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- MCVT
- Stock Information
- Founded
- PYPD 2008
- MCVT 2007
- Country
- PYPD Israel
- MCVT United States
- Employees
- PYPD N/A
- MCVT N/A
- Industry
- PYPD Medical/Dental Instruments
- MCVT Finance Companies
- Sector
- PYPD Health Care
- MCVT Finance
- Exchange
- PYPD Nasdaq
- MCVT Nasdaq
- Market Cap
- PYPD 19.4M
- MCVT 11.6M
- IPO Year
- PYPD 2020
- MCVT N/A
- Fundamental
- Price
- PYPD $2.94
- MCVT $1.96
- Analyst Decision
- PYPD Strong Buy
- MCVT
- Analyst Count
- PYPD 2
- MCVT 0
- Target Price
- PYPD $10.50
- MCVT N/A
- AVG Volume (30 Days)
- PYPD 43.8K
- MCVT 4.5K
- Earning Date
- PYPD 02-12-2025
- MCVT 11-12-2024
- Dividend Yield
- PYPD N/A
- MCVT N/A
- EPS Growth
- PYPD N/A
- MCVT N/A
- EPS
- PYPD N/A
- MCVT 0.05
- Revenue
- PYPD N/A
- MCVT $3,234,265.00
- Revenue This Year
- PYPD N/A
- MCVT N/A
- Revenue Next Year
- PYPD N/A
- MCVT N/A
- P/E Ratio
- PYPD N/A
- MCVT $39.90
- Revenue Growth
- PYPD N/A
- MCVT N/A
- 52 Week Low
- PYPD $2.37
- MCVT $1.75
- 52 Week High
- PYPD $9.20
- MCVT $3.88
- Technical
- Relative Strength Index (RSI)
- PYPD 44.37
- MCVT 49.28
- Support Level
- PYPD $2.60
- MCVT $1.90
- Resistance Level
- PYPD $3.85
- MCVT $2.06
- Average True Range (ATR)
- PYPD 0.38
- MCVT 0.06
- MACD
- PYPD 0.01
- MCVT 0.01
- Stochastic Oscillator
- PYPD 27.03
- MCVT 44.44
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About MCVT Mill City Ventures III Ltd.
Mill City Ventures III Ltd is a non-bank lender and specialty finance company. The company is engaged in the business of providing short-term specialty finance solutions primarily to private businesses, micro-and small-cap public companies, and high-net-worth individuals. The principal specialty finance solutions that they provide are high-interest short-term lending arrangements. Typically, these lending arrangements involve obtaining collateral as security for the borrower's repayment of funds, or personal guarantees from the principals or affiliates of the borrower.